Intensity of statin therapy in primary and secondary prevention: Difference between revisions
Jump to navigation
Jump to search
m (Bot: Adding CME Category::Cardiology) |
No edit summary |
||
(3 intermediate revisions by the same user not shown) | |||
Line 3: | Line 3: | ||
{{CMG}} | {{CMG}} | ||
==High | ==2013 ACC AHA guideline on the treatment of blood cholesterol intensity of statin therapy in primary and secondary prevention== | ||
===High, Moderate, and Low Intensity Statin Therapy=== | |||
{| {{table}} | {| {{table}} | ||
Line 22: | Line 21: | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Disease]] | [[Category:Disease]] |
Latest revision as of 18:26, 28 October 2016
Template:Hypercholesterolemia Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
2013 ACC AHA guideline on the treatment of blood cholesterol intensity of statin therapy in primary and secondary prevention
High, Moderate, and Low Intensity Statin Therapy
High-Intensity Statin Therapy | Moderate-Intensity Statin Therapy | Low-Intensity Statin Therapy |
Atorvastatin (40†)–80 mg Rosuvastatin 20 (40) mg |
Atorvastatin 10 (20) mg Rosuvastatin (5) 10 mg Simvastatin 20–40 mg‡ Pravastatin 40 (80) mg Lovastatin 40 mg Fluvastatin XL 80 mg Fluvastatin 40 mg bid Pitavastatin 2–4 mg |
Simvastatin 10 mg Pravastatin 10–20 mg Lovastatin 20 mg Fluvastatin 20–40 mg Pitavastatin 1 mg |